TY - JOUR
T1 - Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils
AU - Dianzani, C.
AU - Lombardi, G.
AU - Collino, M.
AU - Ferrara, C.
AU - Cassone, M. C.
AU - Fantozzi, R.
PY - 2001
Y1 - 2001
N2 - The neurokinin (NK) substance P (SP), which is a mediator of neurogenic inflammation, has been reported to prime human polymorphonuclear neutrophils (PMNs). The priming effects of SP on PMNs activated by recombinant interleukin-8 (rIL-8) were investigated. SP enhanced, in a dose- and time-dependent way, the rise in cytosolic free-calcium concentration, [Ca2+]i, evoked by the chemokine. The priming effects of SP were abolished by exposing PMNs to a calcium-free medium supplemented with EGTA. The C-terminal peptides SP(4-11) and SP(6-11) but not the N-terminal peptide SP(1-7) shared the priming effects of SP. The selective NK-1 receptor agonist [Sar-9, Met(O)2-ll]SP mimicked the effects of SP, which were not reproduced by the selective NK-2 receptor agonist [βAla-8]-NKA(4-10) or the selective NK-3 agonist senktide. Two selective NK-1 antagonists, CP96,345 and L703,606, dose dependently inhibited SP priming effects. These results demonstrated that SP primes PMNs exposed to rIL-8 and suggested that SP priming effects are receptor mediated.
AB - The neurokinin (NK) substance P (SP), which is a mediator of neurogenic inflammation, has been reported to prime human polymorphonuclear neutrophils (PMNs). The priming effects of SP on PMNs activated by recombinant interleukin-8 (rIL-8) were investigated. SP enhanced, in a dose- and time-dependent way, the rise in cytosolic free-calcium concentration, [Ca2+]i, evoked by the chemokine. The priming effects of SP were abolished by exposing PMNs to a calcium-free medium supplemented with EGTA. The C-terminal peptides SP(4-11) and SP(6-11) but not the N-terminal peptide SP(1-7) shared the priming effects of SP. The selective NK-1 receptor agonist [Sar-9, Met(O)2-ll]SP mimicked the effects of SP, which were not reproduced by the selective NK-2 receptor agonist [βAla-8]-NKA(4-10) or the selective NK-3 agonist senktide. Two selective NK-1 antagonists, CP96,345 and L703,606, dose dependently inhibited SP priming effects. These results demonstrated that SP primes PMNs exposed to rIL-8 and suggested that SP priming effects are receptor mediated.
KW - Cytosolic free-calcium concentration
KW - NK-1 receptor
KW - Neuropeptide
UR - http://www.scopus.com/inward/record.url?scp=0034969155&partnerID=8YFLogxK
U2 - 10.1189/jlb.69.6.1013
DO - 10.1189/jlb.69.6.1013
M3 - Article
SN - 0741-5400
VL - 69
SP - 1013
EP - 1018
JO - Journal of Leukocyte Biology
JF - Journal of Leukocyte Biology
IS - 6
ER -